Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Study reveals non-statin cholesterol drugs could reduce liver cancer risk

Study reveals non-statin cholesterol drugs could reduce liver cancer risk
p p Read More

The third leading cause of cancer mortality accounts for over 700,000 deaths every year

August 2, 2024 liver cancer, National Cancer Institute, News, non-statin cholesterol drugs, Oncology

Researchers reveal CAR-enhancer therapy could help overcome cancer relapse

Researchers reveal CAR-enhancer therapy could help overcome cancer relapse
p p Read More

Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer […]

August 2, 2024 Cancer, CAR T cells, CAR-E therapy, Dana-Farber Cancer Institute, News, Oncology

NHS Scotland, AZ and Scottish universities partner for kidney health research

NHS Scotland, AZ and Scottish universities partner for kidney health research
p p Read More

The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland

August 1, 2024 astrazeneca, chronic kidney disease, News, NHS Scotland, University of Dundee, University of Glasgow

Study finds ovarian cancer-treated women less likely to develop breast cancer

Study finds ovarian cancer-treated women less likely to develop breast cancer
p p Read More

Combined, ovarian and breast cancer affect over 60,000 women in the UK every year

August 1, 2024 Breast Cancer, Manchester University NHS Foundation Trust, News, Oncology, Ovarian Cancer

EPSRC launches two new hubs to transform early disease diagnosis in the UK

EPSRC launches two new hubs to transform early disease diagnosis in the UK
p p Read More

Quantum-based technologies will explore infectious diseases, cancer and dementia

July 31, 2024 disease diagnosis, Engineering and Physical Sciences Research Council, Imperial College London, News, quantum technology, University of Birmingham, University of Cambridge

Apollo and Oxford University enter drug discovery and development collaboration

Apollo and Oxford University enter drug discovery and development collaboration
p p Read More

The latest collaboration marks Apollo’s sixth agreement with a research institution

July 31, 2024 Apollo Therapeutics, autoimmune diseases, drug discovery, News, Oncology, university of oxford

Study reveals new insights into ‘gene misbehaviour’ in healthy populations

Study reveals new insights into ‘gene misbehaviour’ in healthy populations
p p Read More

The findings could support investigations into human genetics and various complex diseases

July 30, 2024 astrazeneca, gene misbehaviour, human genetics and disease, News, Rare diseases, University of Cambridge, Wellcome Sanger Institute

HDR UK and DPUK granted £2m for new motor neurone disease research initiative

HDR UK and DPUK granted £2m for new motor neurone disease research initiative
p p Read More

The rapidly progressive neurological condition affects around 5,000 people in the UK

July 30, 2024 Dementias Platforms UK, Health Data Research UK, MND Research Data Catalyst, motor neurone disease, neurological conditions, News

Study finds 3D-printed blood vessels could improve heart bypass outcomes

Study finds 3D-printed blood vessels could improve heart bypass outcomes
p p Read More

Coronary heart disease is the most common form of heart and circulatory disease

July 29, 2024 artificial blood vessels, cardiovascular diseases, coronary heart disease, heart bypass, Heriot-Watt University, News, University of Edinburgh

MIT study reveals how specific cells in AD become vulnerable and resilient

MIT study reveals how specific cells in AD become vulnerable and resilient
p p Read More

The neurodegenerative condition is recognised as the most common form of dementia

July 29, 2024 Alzheimer's disease, Dementia, Massachusetts Institute of Technology, neurodegenerative diseases, News, reelin, Religious Order Study, Rush Memory and Aging Project

Posts navigation

Posts pagination

« Previous 1 … 35 36 37 … 66 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy